Related Experiment Video

Updated: Jun 12, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Decreased Cyp2E1 mRNA expression in human leucocytes in patients with fibrotic and inflammatory lung diseases

Simone Helmig1, Juliane Döhrel, Joachim Schneider

  • 1Institut und Poliklinik für Arbeits- und Sozialmedizin, der Justus-Liebig Universität, D-35392 Giessen, Germany. simone.helmig@arbmed.med.uni-giessen.de

International Journal of Molecular Medicine
|June 2, 2010
PubMed

Insights

This study found significantly reduced Cytochrome P450 2E1 (CYP2E1) mRNA expression in patients with fibrotic and inflammatory lung diseases. These findings highlight CYP2E1

Area of Science:

  • Biochemistry
  • Toxicology
  • Pulmonology

Background:

  • Cytochrome P450 2E1 (CYP2E1) is a phase I enzyme crucial for activating pro-carcinogens.
  • Significant inter-individual variability exists in CYP2E1 substrate toxicity.
  • Understanding CYP2E1 expression is vital for pharmacology and occupational lung disease research.

Purpose of the Study:

  • To quantify CYP2E1 mRNA expression in patients with fibrotic and inflammatory lung diseases.
  • To investigate the influence of occupational exposures (tobacco smoke, asbestos, silica, organic dust, chemical irritants) on CYP2E1 expression.
  • To examine the association between the CYP2E1 C1053T polymorphism and mRNA levels.

Main Methods:

  • Real-time PCR (LightCycler System) was used for quantitative CYP2E1 mRNA expression analysis.
  • The 2(-DeltaDeltaCT) method was employed for expression calculations.
  • Capillary PCR with melting curve analysis was performed to detect the CYP2E1 C1053T polymorphism.

Main Results:

  • Patients with fibrotic and inflammatory lung diseases exhibited significantly reduced CYP2E1 mRNA expression compared to healthy controls.
  • Exposure to asbestos, organic dust, and chemical irritants was associated with highly significant reductions in CYP2E1 expression.
  • Specific occupational diseases, including asbestosis and obstructive airway diseases, showed markedly decreased CYP2E1 mRNA levels.

Conclusions:

  • A significant decrease in CYP2E1 mRNA expression is demonstrated in patients suffering from fibrotic and inflammatory lung diseases.
  • Occupational exposures contribute to altered CYP2E1 expression patterns in lung disease patients.
  • These findings underscore the role of CYP2E1 in the pathophysiology of occupational and environmental lung diseases.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...